Helper T cells (CD3+CD4+ T cells) and cytotoxic T cells (CD3+CD8+ T cells) play direct and indirect antiviral roles. This study retrospectively explored the clinical significance of peripheral lymphocytes, especially the dynamic analysis of T-cell subsets, in determining coronavirus disease 2019 (COVID-19) severity and progression. Seventy-nine patients with COVID-19 in the Public Health Clinical Center of Chengdu from January to February 2020 were included, 59 of which were analyzed for dynamic peripheral T-cell subsets expression. The neutrophil to CD4+ T lymphocyte ratio (N4R) and neutrophil to CD3+ T lymphocyte ratio (N3R) showed clinical significance in differentiating severe or critically-severe COVID-19, with area under receiver operating characteristic curves (AUCs) of 0.933 and 0.900, respectively (P < 0.05). COVID-19 patients with more baseline peripheral lymphocytes or NK cells were prone to test negative to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after therapy (P < 0.05), and the AUC of NK cells for predicting negative results of SARS-CoV-2 RNA detection after therapy was 0.800. When the number of peripheral CD3+CD4+ and CD3+CD8+ T cells in COVID-19 patients continuously increased 6-9 days after baseline, the period of disease exacerbation could be delayed for more than 2 weeks after admission. Baseline N4R and N3R could be potential biomarkers for assisting in differentiating COVID-19 severity, and dynamically monitoring peripheral CD3+CD4+ and CD3+CD8+ T cells 6-9 days after baseline could help clinicians to evaluate disease progression in COVID-19 patients.
【저자키워드】 COVID-19, Coronavirus disease 2019, Lymphocytes, CD3+CD4+ T cells, neutrophil to CD4+ T lymphocyte ratio/N4R, 【초록키워드】 coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, therapy, Lymphocytes, Antiviral, T cells, severity, neutrophil, NK cell, COVID-19 severity, NK cells, CD8+ T cells, progression, severe acute respiratory syndrome Coronavirus, Disease progression, lymphocyte, T cell, Cytotoxic T cells, clinical, Clinical significance, T-cell, respiratory, characteristic, disease, expression, Admission, COVID-19 patients, Potential biomarker, helper T cells, SARS-CoV-2 RNA detection, Analysis, COVID-19 patient, AUC, Cytotoxic T cell, receiver operating characteristic, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, clinician, help, center, T lymphocyte, CD4+, potential biomarkers, CD3+, helper, peripheral lymphocyte, Public, CD3+CD4+, CD3+CD8+, analyzed, evaluate, subset, baseline, CD4+ T lymphocyte, patients with COVID-19, test negative, 【제목키워드】 Coronavirus disease 2019, severity, monitoring, subset, assist,